Form 4 for TNGX Tango Therapeutics, Inc.
Accepted 2025-06-09 00:00:00 ET · period of report 2025-06-05 · accession 0000950170-25-083906 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-09 | 2025-06-05 | TNGX | Ketchum John B | Dir | A - Grant | $0.00 | +6,250 | 20.9K | +43% | $0 |
| D | 2025-06-09 | 2025-06-05 | TNGX | Ketchum John B | Dir | A - Grant | $0.00 | +37.5K | 37.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-05 | A | A | 6,250 | $0.00 | 20,937 | D | — | — | (F1) These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2026 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-06-05 | A | A | 37,500 | $0.00 | 37,500 | D | $3.51 · — to 2035-06-05 | 37,500 Common Stock | (F2) This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. |